BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, characterized in research literature for its activity at the VEGF/VEGFR2-Akt-eNOS signaling axis and nitric oxide (NO) system modulation
The Importance of Monitoring and Individualized FIP Cat Treatment Each fip cat disease case is unique, and a tailored treatment approach is essential
human bioavailability is unknown Subcutaneous injection Human subcutaneous bioavailability and pharmacokinetics are unknown Factor Convenience Oral capsules No mixing or syringe math Subcutaneous injection Requires reconstitution, sterile supplies, and injection-site planning Factor Evidence limits Oral capsules No controlled human dose, benefit, or safety trial Subcutaneous injection No controlled human dose, benefit, or safety trial Factor Can the amounts be treated as equal
Product is sold strictly for laboratory scientific research (RUO)
Citations General Pharmacokinetic Concepts and Clinical Drug Development
If you are losing weight steadily at 1.0 mg with tolerable side effects, staying there is a perfectly valid strategy